ScholarIQanswers from OpenAlex

Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring

PaperCitations, authors & open-access status

Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring have?

ScholarIQcitation count

Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring has 21 citations in the OpenAlex counts ScholarIQ stores.

When was Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring published?

ScholarIQyear

Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring has 2020 year in the ScholarIQ index.

What is the open-access status of Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring?

ScholarIQoa status

Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring has closed oa status in the ScholarIQ index.

What is the DOI of Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring?

ScholarIQdoi

The DOI for Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring is on the source record.

What is the PMID of Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring?

ScholarIQpmid

The PMID for Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring is on the source record.

What is the OpenAlex record for Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring?

ScholarIQopenalex

The OpenAlex for Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial